uMotif

London, United Kingdom

Clinical Research Clinical Trials Data Services Real-World Evidence

Since 2012 the umotif platform has captured data to support new insights. Combined with our expertise across academic, clinical, RWE, registry, and observational research we power some of the largest virtual trials around the world. Our engaging technology is used by leading academics, CROs, biotechs, medical device, and pharmaceutical companies. Our platform can be deployed quickly in any therapeutic area across all phases of research.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out uMotif on @MedStartr Today #ClinicalTrials #MedicalResearch #ClinicalResearch #DataServices #RealWorldEvidence #MedMo #MedStartrVentures

https://www.medstartr.ai/s/dWUQlkDEuvw

Get Involved in uMotif

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2012
Website: umotif.com/

Disease Areas

Clinical Trials Medical Research

Technologies

CTMSData Management PlatformReal-World DataDecentralized Clinical Trials

🌐Website

What do you think of uMotif?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.